QSS
TGTX icon

Quantitative Systematic Strategies’s TG Therapeutics TGTX Stock Holding History

Quantitative Systematic Strategies’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,117
Closed -$295K – 651
2021
Q1 		$295K Sell
6,117
-4,304
-41% -$207K 0.05% 474
2020
Q4 		$542K Sell
10,421
-3,504
-25% -$118K 0.08% 376
2020
Q3 		$373K Sell
13,925
-7,964
-36% -$183K 0.07% 388
2020
Q2 		$426K Buy
+21,889
New +$353K 0.08% 340
2018
Q3 		– Sell
-11,086
Closed -$146K – 786
2018
Q2 		$146K Buy
+11,086
New +$152K 0.03% 579
2016
Q1 		– Sell
-25,270
Closed -$302K – 742
2015
Q4 		$302K Buy
+25,270
New +$319K 0.08% 708

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Quantitative Systematic Strategies's TGTX Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of TG Therapeutics (TGTX) in Q2 2021, closing a stake of 6,117 shares — an estimated $295K sold.

Quantitative Systematic Strategies first reported a position in TGTX in Q4 2015 and held it in 6 quarters. The position peaked at $542K in Q4 2020. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining TG Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,117 TG Therapeutics shares in Q2 2021, an estimated $295K.
  • Quantitative Systematic Strategies first reported a position in TG Therapeutics in Q4 2015 and held it in 6 quarters.
  • Quantitative Systematic Strategies's TG Therapeutics position peaked at $542K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.